Sphingolipids, mycobacteria and host: Unraveling the tug of war

Sphingolipids, mycobacteria and host: Unraveling the tug of war

Bibliographic Details
Main Authors:	Shakeel Ahmed Mohammed, Reena Vohra Saini, Abhimanyu Kumar Jha, Vijay Hadda, Amit Kumar Singh, Hridayesh Prakash
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	Sphingosine-1phosphate M1 effector macrophages iNOS tuberculosis innate immunity significance
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1003384/full

Similar Items

Nitric oxide promotes differentiation of rat white preadipocytes in culture
by: Hongyun Yan, et al.
Published: (2002-12-01)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
by: Mateusz Matwiejuk, et al.
Published: (2022-11-01)

Myelin basic protein charge isomers change macrophage polarization
by: Tsitsilashvili E, et al.
Published: (2019-01-01)

Sphingolipids as Emerging Mediators in Retina Degeneration
by: M. Victoria Simón, et al.
Published: (2019-06-01)

Crosstalk between Serum and Skin Sphingolipids in Psoriasis
by: Mateusz Matwiejuk, et al.
Published: (2023-10-01)

Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease
by: Joanna A. Motyl, et al.
Published: (2021-06-01)

Nitric oxide synthase: non-canonical expression patterns
by: Mattila eJoshua, et al.
Published: (2014-10-01)

The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
by: Mateusz Matwiejuk, et al.
Published: (2023-07-01)

A specific, non-immune system-related isoform of the human inducible nitric oxide synthase is expressed during differentiation of human stem cells into various cell types
by: Fabian Gather, et al.
Published: (2022-04-01)

Protective Effects of Cirsilineol against Lipopolysaccharide-Induced Inflammation; Insights into HO-1, COX-2, and iNOS Modulation
by: Go Oun Kim, et al.
Published: (2023-05-01)

Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
by: Olivia C. Harden, et al.
Published: (2020-09-01)

Sphingolipids: regulators of crosstalk between apoptosis and autophagy
by: Megan M. Young, et al.
Published: (2013-01-01)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
by: Kana Masuda-Kuroki, et al.
Published: (2023-09-01)

The Role of Sphingolipids in Cancer Immunotherapy
by: Paola Giussani, et al.
Published: (2021-06-01)

Pentagalloyl Glucose, a Major Compound in Mango Seed Kernel, Exhibits Distinct Gastroprotective Effects in Indomethacin-Induced Gastropathy in Rats via Modulating the NO/eNOS/iNOS Signaling Pathway
by: Mona F. Mahmoud, et al.
Published: (2022-02-01)

Effects of sphingolipid metabolism disorders on endothelial cells
by: Yali Lai, et al.
Published: (2022-10-01)

Salivary and serum nitric oxide synthase, macrophage inflammatory protein 1 alpha and macrophage migration inhibitory factor levels in periodontal disease
by: Fatma Oner, et al.
Published: (2024-02-01)

Anti-Inflammatory Effect of Sparstolonin B through Inhibiting Expression of NF-κB and STAT-1
by: Nayeon Kim, et al.
Published: (2022-09-01)

Cuantificación de células endoteliales que expresan VEGF, iNOS y eNOS en el endometrio ovino a los 20, 28 y 35 días de la gestación Quantification of endothelial cells expressing VEGF, iNOS and eNOS in the ovine endometrium at 20, 28 and 35 days of gestation
by: Piedad C Rivas, et al.
Published: (2007-09-01)

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
by: Brianna M. Quinville, et al.
Published: (2021-05-01)

Features of iNOS activity in the skin lesions of patients with psoriasis and concomitant hypertension
by: G.І. Makurina, et al.
Published: (2016-08-01)

iNOS expressing macrophages co-localize with nitrotyrosine staining after myocardial infarction in humans
by: Verena Wilmes, et al.
Published: (2023-03-01)

Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
by: Melinda N. Tea, et al.
Published: (2020-01-01)

Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer
by: Hao Wang, et al.
Published: (2020-07-01)

Editorial: Sphingolipids in infections, diseases, and disorders
by: Farha Naz, et al.
Published: (2024-03-01)

Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
by: Anthony S. Don, et al.
Published: (2014-03-01)

iNOS polymorphism modulates iNOS/NO expression via impaired antioxidant and ROS content in P. vivax and P. falciparum infection
by: Amod Kumar, et al.
Published: (2018-05-01)

Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids
by: Elisabetta Meacci, et al.
Published: (2022-05-01)

Effects of Angiotensin Receptor Blockers on Streptozotocin-Induced Diabetic Cataracts
by: Gaku Ishigooka, et al.
Published: (2023-10-01)

Propofol protects against high glucose-mediated endothelial injury via inhibition of COX2 and iNOS expressions
by: Shao Jiayun, et al.
Published: (2022-03-01)

Dengue induces iNOS expression and nitric oxide synthesis in platelets through IL-1R
by: Mariana Brandi Mendonça Pinheiro, et al.
Published: (2022-12-01)

Strong renal expression of heat shock protein 70, high mobility group box 1, inducible nitric oxide synthase, and nitrotyrosine in mice model of severe malaria
by: Loeki Enggar Fitri, et al.

Sphingolipid Mediators of Myocardial Pathology
by: Anna Kovilakath, et al.
Published: (2020-01-01)

Sphingolipids in ischemic stroke
by: Anastasia A. Rogozhina
Published: (2022-01-01)

Long-Term Dietary Fructose Causes Gender-Different Metabolic and Vascular Dysfunction in Rats: Modulatory Effects of Resveratrol
by: Mehmet Bilgehan Pektaş, et al.
Published: (2015-10-01)

Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level
by: Wael A. Alanazi, et al.
Published: (2023-06-01)

Nitric Oxide-Dependent Pathways as Critical Factors in the Consequences and Recovery after Brain Ischemic Hypoxia
by: Joanna M Wierońska, et al.
Published: (2021-07-01)

Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration
by: Maria Ayub, et al.
Published: (2021-07-01)

Circulating Sphingolipids and Glucose Homeostasis: An Update
by: Sarah Ali-Berrada, et al.
Published: (2023-08-01)

Antineoplastic Agents Targeting Sphingolipid Pathways
by: Alexander Kroll, et al.
Published: (2020-05-01)